Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Rho Kinase Inhibitor V (CAS 1072906-02-5)

0.0(0)
Write a reviewAsk a question

Application:
Rho Kinase Inhibitor V is a cell-permeable and potent, ATP-binding pocket-targeting inhibitor of ROCK-II
CAS Number:
1072906-02-5
Molecular Weight:
321.3
Molecular Formula:
C18H15N3O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

A cell-permeable pyrazolyl carboxamide compound that acts as a potent, ATP-binding pocket-targeting inhibitor of ROCK-II and effectively inhibits the myosin light chain 2 phosphorylation on Thr18/Ser19 in A7r5 cells. It affects the activities of PKA, MRCK, Akt1 and CYP-450 enzymes only at much higher concentrations.


Rho Kinase Inhibitor V (CAS 1072906-02-5) References

  1. Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors.  |  Feng, Y., et al. 2008. J Med Chem. 51: 6642-5. PMID: 18834107
  2. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.  |  Peng, Q., et al. 2009. Inflamm Allergy Drug Targets. 8: 236-46. PMID: 19601884
  3. A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptor.  |  Lotz-Jenne, C., et al. 2016. Oncotarget. 7: 25983-6002. PMID: 27036020
  4. Variations in basement membrane mechanics are linked to epithelial morphogenesis.  |  Chlasta, J., et al. 2017. Development. 144: 4350-4362. PMID: 29038305

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Rho Kinase Inhibitor V, 5 mg

sc-222255
5 mg
$281.00